You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

KENACORT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Kenacort, and when can generic versions of Kenacort launch?

Kenacort is a drug marketed by Delcor Asset Corp and is included in two NDAs.

The generic ingredient in KENACORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KENACORT?
  • What are the global sales for KENACORT?
  • What is Average Wholesale Price for KENACORT?
Summary for KENACORT
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 76
Clinical Trials: 12
DailyMed Link:KENACORT at DailyMed
Drug patent expirations by year for KENACORT
Recent Clinical Trials for KENACORT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sohag UniversityPhase 4
Assiut UniversityPhase 4
Kessler FoundationPhase 2

See all KENACORT clinical trials

US Patents and Regulatory Information for KENACORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp KENACORT triamcinolone diacetate SYRUP;ORAL 012515-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-008 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-010 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.